通过MSH2-MSH6二元化和ATM-p53-p21激活,Lnc-PTCHD4-AS可以抑制胃癌
Jingyun Wang1,2, Yang Mi1,2,3, Xiangdong Sun1,2
1Henan Key Laboratory for Helicobacter pylori and Microbiota and GI Cancer, Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
Aging
|November 28, 2023
概括
一种新的长非编码RNA,PTCHD4-AS,在胃癌 (GC) 中被下调. 抑制PTCHD4-AS抑制GC细胞的增殖,并通过激活ATM-p53-p21通路来增强西斯普拉丁的敏感性.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 遗传学 遗传学 是一个
背景情况:
- 长非编码RNAs (lncRNAs) 在胃癌 (GC) 中的作用仍未得到充分研究.
- PTCHD4-AS是一种保存的lncRNA,在GC中被确定为下调调节.
研究的目的:
- 研究新型lncRNA PTCHD4-AS在胃癌中的功能和机制.
- 探索PTCHD4-AS作为GC治疗点的潜力.
主要方法:
- 在GC细胞系和组织中识别和表征PTCHD4-AS.
- 对PTCHD4-AS表达的分析,以应对DNA损伤剂.
- 研究PTCHD4-AS在细胞周期,细胞亡和药物敏感性中的作用.
- 涉及蛋白质-RNA相互作用和途径分析的分子机制研究.
主要成果:
- PTCHD4-AS被保存,在GC下调,并通过DNA损伤转录诱导.
- PTCHD4-AS上调会导致G2/M细胞周期停止,并增强GC细胞中西斯普拉丁诱导的亡.
- PTCHD4-AS直接与MSH2-MSH6二分体结合,促进ATM-p53-p21通路的激活.
结论:
- PTCHD4-AS抑制GC细胞的增殖,并增加对西斯的敏感性.
- 该机制涉及PTCHD4-AS与MSH2-MSH6结合并激活ATM-p53-p21信号通路.
- PTCHD4-AS代表了胃癌治疗的潜在治疗标.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:37DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
01:23Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K